1-5 of 5
Maryann Gallagher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer

Free
Amy S. Clark, Nicholas P. McAndrew, Andrea Troxel, Michael Feldman, Priti Lal, Mark Rosen, Jessica Burrell, Colleen Redlinger, Maryann Gallagher, Angela R. Bradbury, Susan M. Domchek, Kevin R. Fox, Peter J. O'Dwyer, Angela M. DeMichele
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2072–2079.
https://doi.org/10.1158/1078-0432.CCR-18-0790
Published: 01 April 2019
View articletitled, Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer
Open the PDF for Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment

Free
Angela DeMichele, Amy S. Clark, Kay See Tan, Daniel F. Heitjan, Kristi Gramlich, Maryann Gallagher, Priti Lal, Michael Feldman, Paul Zhang, Christopher Colameco, David Lewis, Melissa Langer, Noah Goodman, Susan Domchek, Keerthi Gogineni, Mark Rosen, Kevin Fox, Peter O'Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 995–1001.
https://doi.org/10.1158/1078-0432.CCR-14-2258
Published: 01 March 2015
View articletitled, CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
Open the PDF for CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin

Free
Joshua H. Bilenker, Keith T. Flaherty, Mark Rosen, Lisa Davis, Maryann Gallagher, James P. Stevenson, Weijing Sun, David Vaughn, Bruce Giantonio, Ross Zimmer, Mitchell Schnall, Peter J. O'Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1527–1533.
https://doi.org/10.1158/1078-0432.CCR-04-1434
Published: 02 March 2005
View articletitled, Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin
Open the PDF for Phase I Trial of Combretastatin A-4 Phosphate with Carboplatin in another window
Journal Articles

Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days

Free
James P. Stevenson, Weijing Sun, Maryann Gallagher, Robert Johnson, David Vaughn, Lynn Schuchter, Kenneth Algazy, Stephen Hahn, Nathan Enas, Diane Ellis, Donald Thornton, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2524–2529.
Published: 01 August 2002
View articletitled, Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days
Open the PDF for Phase I Trial of the Cryptophycin Analogue LY355703 Administered as an Intravenous Infusion on a Day 1 and 8 Schedule Every 21 Days in another window
Journal Articles

c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)

Free
Peter J. O’Dwyer, James P. Stevenson, Maryann Gallagher, Amy Cassella, Irina Vasilevskaya, Brett P. Monia, Jon Holmlund, F. Andrew Dorr, Kang-Shen Yao
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 3977–3982.
Published: 01 December 1999
View articletitled, c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A)
Open the PDF for c-raf-1 Depletion and Tumor Responses in Patients Treated with the c-raf-1 Antisense Oligodeoxynucleotide ISIS 5132 (CGP 69846A) in another window